They demonstrated TRIM3's inhibitory effect on c-myc transcriptional activity and expression levels in glioblastoma by employing the c-myc-driven luciferase reporter gene in U87 MG and LN 229 GBM cell lines (Chen et al. 2014). This evidence concerns the gene MYC and glioblastoma.